Breaking news on biotech stocks and catalysts which includes FDA announcements, license agreements, and clinical trial data releases.

Novavax $NVAX Explosive Sales Growth, New Approval For COVID Vaccine In South Korea

Novavax $NVAX stock moved 2.8% higher into the close on August 12, 2022, after the company announced that South Korea had approved its COVID-19 protein-based vaccine. Protein vaccines contain proteins…

Continue ReadingNovavax $NVAX Explosive Sales Growth, New Approval For COVID Vaccine In South Korea